CTX-101

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCTX-101

Drug Alias NameAlloCSC 01CTX-101

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac stem cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTigenix Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCoretherapix Sl

Active IndicationsN/A

Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A